By contrast, the progression rate of American SCA3 patients in the Clinical Research Consortium for Spinocerebellar Ataxias (CRC‐SCA) study was somewhat slower with a mean yearly increase of 0.65 points.7 The gene discussed is ATXN3; the disease is colorectal carcinoma.